Slaying RAS with a synthetic lethal weapon.
Bommi-Reddy
Archana
A
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
Kaelin
William G
WG
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000235:genetics; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D008322:Mammals / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics; D015689:Oncogene Protein p21(ras) / Q000037:antagonists & inhibitors* / Q000235:genetics
D000970:Antineoplastic Agents; D015689:Oncogene Protein p21(ras)